Cumberland Pharmaceuticals CPIX Share Repurchase Authorization Limit
Share Repurchase Authorization Limit at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's share repurchase authorization limit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's share repurchase authorization limit?
- Cumberland Pharmaceuticals (CPIX) reported share repurchase authorization limit of $2.1M in Q1 2026.
- How has Cumberland Pharmaceuticals's share repurchase authorization limit changed year-over-year?
- Cumberland Pharmaceuticals's share repurchase authorization limit decreased by 4.5% year-over-year, from $2.2M to $2.1M.
- What does share repurchase authorization limit mean?
- This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.